Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Caterina De Rosa
Observed names:
C. de Rosa,
Caterina de Rosa,
De Rosa, Caterina
Institution:
University of Campania "Luigi Vanvitelli"
Observed institutions:
University of Campania "Luigi Vanvitelli",
Federico II University Hospital,
University of Naples Federico II
ORCID:
0000-0001-6540-0708
Observed ORCID:
0000-0001-6540-0708
OpenAlex ID:
A5101594386
PRDM Proteins: Molecular Mechanisms in Signal Transduction and Transcriptional Regulation
2013
·
Erika Di Zazzo
, Caterina De Rosa
, et al.
·
Biology
·
101
PDF
Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells
2019
·
Valentina Rossi
, Erika Di Zazzo
, et al.
·
Frontiers in Pharmacology
·
28
PDF
Identification of a functional estrogen‐responsive enhancer element in the promoter 2 of PRDM2 gene in breast cancer cell lines
2011
·
Ciro Abbondanza
, Caterina De Rosa
, et al.
·
Journal of Cellular Physiology
·
27
Expression of RIZ1 protein (Retinoblastoma‐interacting zinc‐finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2
2009
·
Valentina Rossi
, Stefania Staibano
, et al.
·
Journal of Cellular Physiology
·
26
Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues
2009
·
Luigi Rossiello
, Francesco D'Andrea
, et al.
·
Wound Repair and Regeneration
·
22
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC
2024
·
Caterina De Rosa
, Viviana De Rosa
, et al.
·
Scientific Reports
·
21
PDF
ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors
2023
·
Cristina Terlizzi
, Viviana De Rosa
, et al.
·
Cancer & Metabolism
·
21
PDF
Addition of metformin to anti-PD-1/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients
2025
·
Luisa Amato
, Caterina De Rosa
, et al.
·
Cell Death and Disease
·
19
PDF
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer
2024
·
Caterina De Rosa
, Francesca Iommelli
, et al.
·
Biomedicines
·
19
PDF
Searching for a Putative Mechanism of RIZ2 Tumor-Promoting Function in Cancer Models
2021
·
Monica Rienzo
, Anna Sorrentino
, et al.
·
Frontiers in Oncology
·
18
PDF
Silencing of YY1 Downregulates RIZ1 Promoter in Human Osteosarcoma
2008
·
Ciro Abbondanza
, Filomena de Nigris
, et al.
·
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
·
17
Oreacerebrosides: Bioactive Cerebrosides with a Triunsaturated Sphingoid Base from the Sea Star Oreaster reticulatus
2007
·
Valeria Costantino
, Caterina de Rosa
, et al.
·
European Journal of Organic Chemistry
·
17
Exploring the putative role of PRDM1 and PRDM2 transcripts as mediators of T lymphocyte activation
2023
·
Erika Di Zazzo
, Monica Rienzo
, et al.
·
Journal of Translational Medicine
·
16
PDF
Highlighting chromosome loops in DNA-picked chromatin (DPC)
2011
·
Ciro Abbondanza
, Caterina De Rosa
, et al.
·
Epigenetics
·
11
PDF
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer
2025
·
Caterina De Rosa
, Floriana Morgillo
, et al.
·
iScience
·
10
Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study
2024
·
Luisa Amato
, Caterina De Rosa
, et al.
·
Cancers
·
9
PDF
Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer
2024
·
Luisa Amato
, Daniela Omodei
, et al.
·
Cancers
·
8
PDF
Novel applications of liquid Biopsy: Comprehensive methodology for circulating biomarker exploration in peripheral blood
2025
·
Caterina De Rosa
, Luisa Amato
, et al.
·
The Journal of Liquid Biopsy
·
6
PDF
Adherence, persistence and efficacy of dasatinib and nilotinib in the treatment of patients resistant or intolerant to imatinib with chronic myeloid leukemia in chronic phase: an Italian multicenter study over two years in real life
2021
·
Fiorenzo Santoleri
, Elena Ranucci
, et al.
·
Current Medical Research and Opinion
·
6
Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System
2025
·
Hamid Heydari Sheikhhossein
, Luisa Amato
, et al.
·
International Journal of Molecular Sciences
·
5
PDF
Truncated PNA-functionalized porous silicon biosensor for low-cost and early detection of troponin T in myocardial infarction
2025
·
Maria Grazia Nolli
, Alessio Bartocci
, et al.
·
Talanta
·
2
Discovery of N -substituted-2-oxoindolin benzoylhydrazines as c-MET/SMO modulators in EGFRi-resistant non-small cell lung cancer
2024
·
Stefano Tomassi
, Benito Natale
, et al.
·
RSC Medicinal Chemistry
·
2
PDF
The evolving landscape of first-line and subsequent therapies in EGFR-mutated NSCLC: efficacy, resistance, and tolerability
2026
·
Carminia Maria Della Corte
, Caterina De Rosa
, et al.
·
Exploration of Targeted Anti-tumor Therapy
·
1
PDF
Effect of Soluble Factors Released from Porcine Freeze-Dried Lung Tissue (FDLT) on Modulation of Cell Growth and EMT Signature in Non-Small Cell Lung Cancer (NSCLC)—A Preliminary In Vitro Study
2025
·
Umme Samia
, Daniela Omodei
, et al.
·
International Journal of Molecular Sciences
·
1
PDF
Tumor Extracellular Vesicles (TEVs) as a Tool for Investigation of Circulating Tumor and Immune Features in SCLC
2026
·
Luisa Amato
, Caterina De Rosa
, et al.
·
The Journal of Liquid Biopsy
PDF
Show more works
View as search
Works count:
53
Citation count:
413
H-index:
13
I10-index:
15
Year
Topic
Type